TLR4 and infection: The inhibition of infections by respiratory viruses, such as respiratory syncytial virus (RSV) and influenza A virus (IAV), by pulmonary surfactants that block TLR4, along with immune modulation, supports the potential role of TLR4/2 in pulmonary infection by SARS-CoV-2 and disease pathogenesis [94,95,96].